These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32999568)
21. Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing. Hao Y; Wang X; Wang L; Lu Y; Mao Z; Ge S; Dai K Bone; 2015 Dec; 81():702-711. PubMed ID: 26434668 [TBL] [Abstract][Full Text] [Related]
22. Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost. Martin KE; Yu J; Campbell HE; Abarca J; White TJ J Manag Care Pharm; 2011 Oct; 17(8):596-609. PubMed ID: 21942301 [TBL] [Abstract][Full Text] [Related]
23. Exercise prevented the lansoprazole-induced reduction of anti-osteoporotic efficacy of alendronate in androgen deficiency rats. Cegieła U; Pytlik M; Folwarczna J; Miozga R; Piskorz S; Nowak D Acta Pol Pharm; 2014; 71(3):485-95. PubMed ID: 25265829 [TBL] [Abstract][Full Text] [Related]
24. The influence of alendronate on spine fusion in an osteoporotic animal model. Nakao S; Minamide A; Kawakami M; Boden SD; Yoshida M Spine (Phila Pa 1976); 2011 Aug; 36(18):1446-52. PubMed ID: 21240048 [TBL] [Abstract][Full Text] [Related]
25. Treatment for osteoporosis in people with ß-thalassaemia. Bhardwaj A; Swe KM; Sinha NK; Osunkwo I Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506 [TBL] [Abstract][Full Text] [Related]
26. Effect of alendronate on fracture healing and bone remodeling in dogs. Peter CP; Cook WO; Nunamaker DM; Provost MT; Seedor JG; Rodan GA J Orthop Res; 1996 Jan; 14(1):74-9. PubMed ID: 8618170 [TBL] [Abstract][Full Text] [Related]
27. Alendronate prolongs the reversal-resorption phase in human cortical bone remodeling. Borggaard XG; Roux JP; Delaisse JM; Chavassieux P; Andreasen CM; Andersen TL Bone; 2022 Jul; 160():116419. PubMed ID: 35413490 [TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures. Johnell O; Jönsson B; Jönsson L; Black D Pharmacoeconomics; 2003; 21(5):305-14. PubMed ID: 12627984 [TBL] [Abstract][Full Text] [Related]
29. AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model. Shaul JL; Hill RS; Bouxsein ML; Burr DB; Tilton AK; Howe JG Bone; 2022 Jan; 154():116246. PubMed ID: 34744020 [TBL] [Abstract][Full Text] [Related]
31. Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial. Nagahama K; Kanayama M; Togawa D; Hashimoto T; Minami A J Neurosurg Spine; 2011 Apr; 14(4):500-7. PubMed ID: 21275549 [TBL] [Abstract][Full Text] [Related]
32. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479 [TBL] [Abstract][Full Text] [Related]
33. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing? Ha KY; Park KS; Kim SI; Kim YH Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489 [TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses. Zhou J; Ma X; Wang T; Zhai S Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112 [TBL] [Abstract][Full Text] [Related]
35. Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals. Oliveira D; Hassumi JS; Gomes-Ferreira PH; Polo TO; Ferreira GR; Faverani LP; Okamoto R J Appl Oral Sci; 2017; 25(1):42-52. PubMed ID: 28198975 [TBL] [Abstract][Full Text] [Related]
36. Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats. Faverani LP; Polo TOB; Ramalho-Ferreira G; Momesso GAC; Hassumi JS; Rossi AC; Freire AR; Prado FB; Luvizuto ER; Gruber R; Okamoto R Clin Oral Investig; 2018 Jan; 22(1):255-265. PubMed ID: 28357643 [TBL] [Abstract][Full Text] [Related]
37. Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study. Lau EMC; Dinavahi R; Woo YC; Wu CH; Guan J; Maddox J; Tolman C; Yang W; Shin CS Osteoporos Int; 2020 Apr; 31(4):677-685. PubMed ID: 32047951 [TBL] [Abstract][Full Text] [Related]
38. A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis. Devogelaer JP Drug Saf; 1998 Aug; 19(2):141-54. PubMed ID: 9704250 [TBL] [Abstract][Full Text] [Related]
40. A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05. Hagino H; Sugimoto T; Tanaka S; Sasaki K; Sone T; Nakamura T; Soen S; Mori S Osteoporos Int; 2021 Nov; 32(11):2301-2311. PubMed ID: 34002252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]